Proteolytic fragments or recombinant peptides containing certain domains of fibronectin can inhibit integrin-mediated adhesion, angiogenesis and metastasis in various experimental tumour models (36–39; reviewed in refs. 21,41). The gene discussed is FN1; the disease is neoplasm.